Vasoactive intestinal peptide (VIP) prevents killing of virulent and phoP mutant Salmonella typhimurium by inhibiting IFN-gamma stimulated NADPH oxidative pathways in murine macrophages.

Foster, N

Vasoactive intestinal peptide (VIP) prevents killing of virulent and phoP mutant Salmonella typhimurium by inhibiting IFN-gamma stimulated NADPH oxidative pathways in murine macrophages. [electronic resource] - Cytokine Nov 2006 - 134-40 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1043-4666

10.1016/j.cyto.2006.11.005 doi


Animals
Bacterial Proteins--genetics
Captopril--analogs & derivatives
Cell Line
Gene Expression--drug effects
Interferon-gamma--pharmacology
Macrophages--drug effects
Membrane Glycoproteins--genetics
Mice
Microbial Viability--drug effects
Mutation
NADPH Oxidase 2
NADPH Oxidases--genetics
RNA, Messenger--genetics
Reactive Oxygen Species--metabolism
Reverse Transcriptase Polymerase Chain Reaction
Salmonella typhimurium--drug effects
Vasoactive Intestinal Peptide--pharmacology